camptothecin has been researched along with folic acid in 50 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 11 (22.00) | 29.6817 |
2010's | 34 (68.00) | 24.3611 |
2020's | 5 (10.00) | 2.80 |
Authors | Studies |
---|---|
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Adler, G; Lutz, MP | 1 |
Höffken, K; Kliche, KO; Kubsch, K; Masri-Zada, R; Raida, M | 1 |
Curley, SA; Ellis, LM; Gentner, B; Parikh, AA; Vauthey, JN; Wu, TT | 1 |
Baba, E; Fujishima, H; Harada, M; Kikuchi, I; Mitsugi, K; Miyanaga, O; Nakano, S; Ueda, A | 1 |
Chen, Y; Kholodovych, V; Paranjpe, PV; Sinko, PJ; Stein, S; Welsh, W | 1 |
Paranjpe, PV; Sinko, PJ; Stein, S | 1 |
Assenat, E; Duffour, J; Ychou, M | 1 |
Doorneweerd, DD; Henne, WA; Hilgenbrink, AR; Kularatne, SA; Low, PS | 1 |
Caca, K; Feisthammel, J; Mössner, J; Schoppmeyer, K; Schulze, M; Wiedmann, M | 1 |
Feng, L; Gu, B; Han, X; Liu, J; Liu, M; Liu, Y; Lu, W; Xie, C; Zhan, C | 1 |
Choi, MK; Chung, SJ; Jin, QR; Kim, DD; Shim, CK; Shim, WS; Song, IS; Tian, GY; Yang, SG | 1 |
Atyabi, F; Azizi, E; Dinarvand, R; Ebrahimnejad, P; Jaafari, MR; Nomani, AR; Rad-Malekshahi, M; Sajadi, A | 1 |
Liu, L; Xia, J; Zhang, L; Zhang, Z; Zhao, Q | 1 |
Atyabi, F; Dinarvand, R; Ebrahimnejad, P; Jafari, MR; Tabasi, SA | 1 |
Gao, Y; Li, Q; Liu, C; Su, L; Sun, B; Wang, Y; Zhang, B; Zhao, D; Zhao, Q; Zhao, X; Zu, Y | 1 |
Beninati, S; Desideri, A; Galbiati, A; Mattioli, P; Morozzo Della Rocca, B; Paradossi, G; Tabolacci, C | 1 |
Li, Z; Lu, J; Tamanoi, F; Zink, JI | 1 |
Jiang, R; Li, Y; Sun, Z; Wang, D; Zhang, Q; Zhao, D; Zhao, X; Zu, B; Zu, Y | 2 |
Cheng, T; Guan, XM; Lan, JF; Liu, XY; Shen, JM; Zhang, HX | 1 |
Yao, J; Zhang, Z | 1 |
An, F; Diao, X; Hao, X; Li, W; Liu, Z; Wang, C; Yang, Y; Zhang, X | 1 |
Backendorf, C; Chatzopoulou, A; den Dulk, H; Kros, A; Lamers, GE; Morrhayim, J; Porta, F; Schaaf, M; Zink, JI | 1 |
Cao, J; Cui, S; Gu, Y; Qian, Z; Zhu, H | 1 |
Li, Z; Liu, Z; Pu, F; Qu, X; Ren, J; Yang, X | 1 |
Carron, JD; Hakenjos, J; Henne, KL; Henne, WA; Kularatne, SA | 1 |
Besznyák, I; Bursics, A; Dede, K; Fekete, A; Kőszegi, G; Láng, I; Mersich, T; Mester, G; Pörneczi, B | 1 |
Bloomfield, A; Dorton, R; Guan, J; Leamon, CP; Nelson, M; Reddy, JA; Vetzel, M | 1 |
Chen, M; Chen, Z; Li, X; Liu, C; Luo, X; Yuan, J; Zhao, Y | 1 |
Chen, RC; Chen, WT; Kang, ST; Lin, JL; Wang, CH; Yeh, CK | 1 |
Chen, HP; Chen, MH; Liu, TY; Tung, FI | 1 |
Chen, Y; Feng, Y; Fu, S; Qin, X; Sun, X; Wu, J; Yang, B; You, H; Yu, Y; Zhang, G | 1 |
Li, Q; Liang, H; Sun, B; Wang, W; Xu, J; Zeng, Z; Zhao, X | 1 |
Choi, HG; Choi, Y; Jeong, JH; Kim, JO; Thapa, RK; Yong, CS; Youn, YS | 1 |
Duan, X; Fan, L; Li, W; Qiao, Y; Wu, H; Yang, T; Zhu, L | 1 |
Chen, M; Chen, Z; Li, X; Luo, X; Xie, S; Zhang, Y | 1 |
Gao, YE; Hou, M; Kang, Y; Liu, S; Shi, X; Xu, Z; Xue, P | 1 |
Enoch, IVMV; Ramasamy, S; Sam David, RJR | 1 |
Chen, Y; Fan, Z; Hou, Z; Li, Y; Lin, J; Ma, J; Su, G; Xie, L; Zhang, H; Zhang, Y; Zhu, X | 1 |
Bai, S; Gao, YE; Hou, M; Kang, Y; Li, B; Ma, X; Shi, X; Xiao, B; Xu, Z; Xue, P | 1 |
Dahiru, NS; Dramou, P; Fizir, M; He, H; Itatahine, A; Mehdi, YA; Taleb, A; Wei, L; Zhang, J | 1 |
Chakraborty, A; Chakraborty, P; Das, S; Nandi, AK; Pal, S; Panja, A | 1 |
Ao, M; Cao, Y; Hao, L; Hu, Z; Huang, J; Li, A; Li, P; Liu, J; Liu, Y; Ran, H; Wang, Z; Xu, F; Xu, J; Yao, Y | 1 |
Decker, T; Denzlinger, C; Fischer von Weikersthal, L; Freiberg-Richter, J; Giessen-Jung, C; Graeven, U; Heinemann, V; Held, S; Jung, A; Kirchner, T; Modest, DP; Peuser, B; Peveling Genannt Reddemann, C; Schenk, M; Schuch, G; Schwaner, I; Stahler, A; Stintzing, S; Uhlig, J; Vehling-Kaiser, U | 1 |
Alinejad, A; Hashemzadeh, H; Raissi, H | 1 |
Alexander, A; Arivarasu, A; Enoch, IVMV; Kaliyamoorthy, K; Pillai, AS; Ramasamy, S | 1 |
Havaldar, DV; Moholkar, DN; Pawar, KD; Sadalage, PS | 1 |
Fu, T; Li, Y; Liu, Y; Long, W; Stang, PJ; Tan, W; Yan, Y; Zhang, P; Zhao, Z; Zhou, Z | 1 |
Chen, Y; Cheng, J; Jiao, Q; Shao, Y; Wang, X; Xiang, L; Zheng, X; Zhou, S | 1 |
2 review(s) available for camptothecin and folic acid
Article | Year |
---|---|
[Chemotherapy of colorectal carcinoma].
Topics: Administration, Oral; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carcinoma; Chemotherapy, Adjuvant; Clinical Trials as Topic; Colorectal Neoplasms; Drug Administration Schedule; Fluorouracil; Folic Acid; Humans; Irinotecan; Neoadjuvant Therapy; Organoplatinum Compounds; Oxaliplatin; Palliative Care; Survival Analysis; Treatment Outcome | 2001 |
[Irinotecan for the treatment of metastatic colorectal cancer].
Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Capecitabine; Clinical Trials as Topic; Colorectal Neoplasms; Deoxycytidine; Fluorouracil; Folic Acid; Humans; Irinotecan; Maximum Tolerated Dose; Multicenter Studies as Topic; Pharmacogenetics | 2006 |
4 trial(s) available for camptothecin and folic acid
Article | Year |
---|---|
Chronomodulated chemotherapy in metastatic gastrointestinal cancer combining 5-FU and sodium folinate with oxaliplatin, irinotecan or gemcitabine: the Jena experience in 79 patients.
Topics: Antineoplastic Combined Chemotherapy Protocols; Biliary Tract Neoplasms; Camptothecin; Colorectal Neoplasms; Deoxycytidine; Female; Fluorouracil; Folic Acid; Gastrointestinal Neoplasms; Gemcitabine; Humans; Irinotecan; Male; Middle Aged; Neoplasm Metastasis; Organoplatinum Compounds; Oxaliplatin; Pancreatic Neoplasms; Stomach Neoplasms | 2002 |
Phase I study of CPT-11 and bolus 5-FU/ l-leucovorin in patients with metastatic colorectal cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Colorectal Neoplasms; Female; Fluorouracil; Folic Acid; Humans; Infusions, Intravenous; Irinotecan; Leucovorin; Male; Maximum Tolerated Dose; Middle Aged; Neoplasm Metastasis; Treatment Outcome | 2004 |
Irinotecan with 5-FU/FA in advanced biliary tract adenocarcinomas: a multicenter phase II trial.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Agents; Biliary Tract Neoplasms; Camptothecin; Female; Fluorouracil; Folic Acid; Humans; Irinotecan; Male; Middle Aged; Survival Analysis; Vitamin B Complex | 2007 |
Sequential Versus Combination Therapy of Metastatic Colorectal Cancer Using Fluoropyrimidines, Irinotecan, and Bevacizumab: A Randomized, Controlled Study-XELAVIRI (AIO KRK0110).
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Camptothecin; Colorectal Neoplasms; Deoxycytidine; Drug Administration Schedule; Female; Fluorouracil; Folic Acid; Humans; Irinotecan; Leucovorin; Male | 2019 |
44 other study(ies) available for camptothecin and folic acid
Article | Year |
---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Perioperative complications in patients undergoing major liver resection with or without neoadjuvant chemotherapy.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Camptothecin; Colonic Neoplasms; Female; Fluorouracil; Folic Acid; Hepatectomy; Humans; Irinotecan; Leucovorin; Liver Neoplasms; Male; Middle Aged; Neoadjuvant Therapy; Postoperative Complications; Retrospective Studies | 2003 |
Tumor-targeted bioconjugate based delivery of camptothecin: design, synthesis and in vitro evaluation.
Topics: Animals; Antineoplastic Agents, Phytogenic; Camptothecin; Carboxylic Acids; Carrier Proteins; Cell Survival; Chemistry, Pharmaceutical; CHO Cells; Cricetinae; Drug Delivery Systems; Drug Design; Drug Stability; Electrophoresis, Polyacrylamide Gel; Fluorescent Dyes; Folate Receptors, GPI-Anchored; Folic Acid; Humans; KB Cells; Lactones; Magnetic Resonance Spectroscopy; Models, Molecular; Receptors, Cell Surface; Spectroscopy, Fourier Transform Infrared | 2004 |
Tumor-targeted and activated bioconjugates for improved camptothecin delivery.
Topics: Amino Acids; Animals; Antineoplastic Agents; Camptothecin; Cathepsin B; Cell Line, Tumor; Drug Delivery Systems; Drug Stability; Esters; Female; Folic Acid; Humans; Hydrolysis; Models, Molecular; Molecular Conformation; Neoplasm Transplantation; Polyethylene Glycols; Rats; Rats, Inbred F344; Xenograft Model Antitumor Assays | 2005 |
Synthesis and activity of a folate peptide camptothecin prodrug.
Topics: Binding, Competitive; Camptothecin; Carrier Proteins; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Folate Receptors, GPI-Anchored; Folic Acid; Humans; In Vitro Techniques; Molecular Structure; Prodrugs; Receptors, Cell Surface; Stereoisomerism; Time Factors | 2006 |
9-NC-loaded folate-conjugated polymer micelles as tumor targeted drug delivery system: preparation and evaluation in vitro.
Topics: Antineoplastic Agents; Camptothecin; Cell Line, Tumor; Drug Delivery Systems; Drug Evaluation, Preclinical; Folic Acid; HeLa Cells; Humans; Micelles; Neoplasms; Polymers | 2009 |
Decreased urinary secretion of belotecan in folic acid-induced acute renal failure rats due to down-regulation of Oat1 and Bcrp.
Topics: Acridines; Acute Kidney Injury; Animals; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Calcium Channel Blockers; Camptothecin; Down-Regulation; Folic Acid; Glomerular Filtration Rate; Indicators and Reagents; Kidney; Male; Organic Anion Transport Protein 1; p-Aminohippuric Acid; Rats; Rats, Sprague-Dawley; Tetrahydroisoquinolines; Verapamil; Vitamin B Complex | 2009 |
Preparation and in vitro evaluation of actively targetable nanoparticles for SN-38 delivery against HT-29 cell lines.
Topics: Buffers; Camptothecin; Cell Death; Drug Delivery Systems; Folic Acid; HT29 Cells; Humans; Irinotecan; Lactic Acid; Microscopy, Fluorescence; Nanoparticles; Polyethylene Glycols; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer | 2010 |
Functional graphene oxide as a nanocarrier for controlled loading and targeted delivery of mixed anticancer drugs.
Topics: Antineoplastic Agents; Camptothecin; Carbon; Cell Line, Tumor; Cell Survival; Doxorubicin; Drug Carriers; Drug Delivery Systems; Folic Acid; Humans; Microscopy, Atomic Force; Rhodamines; Solutions; Spectrometry, Fluorescence; Spectrophotometry, Ultraviolet; Spectroscopy, Fourier Transform Infrared | 2010 |
Characterization, blood profile and biodistribution properties of surface modified PLGA nanoparticles of SN-38.
Topics: Animals; Antineoplastic Agents, Phytogenic; Camptothecin; Chemistry, Pharmaceutical; Drug Carriers; Folic Acid; Injections, Intravenous; Irinotecan; Lactic Acid; Molecular Structure; Nanoparticles; Polyethylene Glycols; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Rats; Rats, Wistar; Surface Properties; Tissue Distribution | 2011 |
Preparation, characterization and targeting of micronized 10-hydroxycamptothecin-loaded folate-conjugated human serum albumin nanoparticles to cancer cells.
Topics: Antineoplastic Agents, Phytogenic; Calorimetry, Differential Scanning; Camptothecin; Cell Line, Tumor; Chemistry, Pharmaceutical; Drug Carriers; Drug Delivery Systems; Fluorescein-5-isothiocyanate; Fluorescent Dyes; Folic Acid; Humans; Microscopy, Confocal; Microscopy, Electron, Scanning; Nanomedicine; Nanoparticles; Particle Size; Serum Albumin; X-Ray Diffraction | 2011 |
Targeting tumor cells through chitosan-folate modified microcapsules loaded with camptothecin.
Topics: Adsorption; Animals; Antineoplastic Agents; Camptothecin; Capsules; Cell Proliferation; Chitosan; Drug Carriers; Drug Delivery Systems; Drug Screening Assays, Antitumor; Folic Acid; HeLa Cells; Humans; Mice; Molecular Structure; NIH 3T3 Cells; Structure-Activity Relationship; Surface Properties; Tumor Cells, Cultured | 2011 |
In vivo tumor suppression efficacy of mesoporous silica nanoparticles-based drug-delivery system: enhanced efficacy by folate modification.
Topics: Animals; Antineoplastic Agents; Camptothecin; Cell Line, Tumor; Drug Delivery Systems; Folic Acid; Humans; Mice; Mice, Inbred BALB C; Nanoparticles; Pancreatic Neoplasms; Silicates; Transplantation, Heterologous | 2012 |
A novel preparation method for camptothecin (CPT) loaded folic acid conjugated dextran tumor-targeted nanoparticles.
Topics: Antineoplastic Agents, Phytogenic; Calorimetry, Differential Scanning; Camptothecin; Carbon Dioxide; Chemistry, Pharmaceutical; Dextrans; Dimethyl Sulfoxide; Drug Carriers; Folic Acid; Microscopy, Electron, Scanning; Nanoparticles; Particle Size; Spectroscopy, Fourier Transform Infrared; Surface Properties; X-Ray Diffraction | 2011 |
Preparation and characterization of camptothecin (CPT)-loaded folate-conjugated dextran nanoparticles for tumor-targeted drug delivery using supercritical antisolvent method.
Topics: Antineoplastic Agents, Phytogenic; Calorimetry, Differential Scanning; Camptothecin; Chemistry, Pharmaceutical; Chromatography, Supercritical Fluid; Dextrans; Drug Carriers; Drug Compounding; Folic Acid; Kinetics; Microscopy, Electron, Scanning; Nanoparticles; Nanotechnology; Particle Size; Solubility; Solvents; Spectroscopy, Fourier Transform Infrared; Technology, Pharmaceutical; X-Ray Diffraction | 2011 |
Luminescent/magnetic hybrid nanoparticles with folate-conjugated peptide composites for tumor-targeted drug delivery.
Topics: Antineoplastic Agents, Phytogenic; Cadmium Compounds; Camptothecin; Cell Line, Tumor; Chitosan; Drug Delivery Systems; Folic Acid; Humans; Luminescence; Luminescent Agents; Magnetite Nanoparticles; Micelles; Neoplasms; Oligopeptides; Quantum Dots; Tellurium | 2012 |
Preparation of irinotecan-loaded folate-targeted liposome for tumor targeting delivery and its antitumor activity.
Topics: Animals; Antineoplastic Agents, Phytogenic; Camptothecin; Drug Delivery Systems; Folic Acid; Irinotecan; Liposomes; Mice; Mice, Inbred ICR; Random Allocation; Rats; Xenograft Model Antitumor Assays | 2012 |
Carrier-free, functionalized drug nanoparticles for targeted drug delivery.
Topics: Antineoplastic Agents, Phytogenic; Camptothecin; Cell Line, Tumor; Cell Survival; Drug Delivery Systems; Folate Receptors, GPI-Anchored; Folic Acid; Humans; Maleic Anhydrides; Nanoparticles; Neoplasms; Polyethylene Glycols | 2012 |
Folic acid-modified mesoporous silica nanoparticles for cellular and nuclear targeted drug delivery.
Topics: Antineoplastic Agents; Blotting, Western; Camptothecin; Cell Line, Tumor; Drug Carriers; Folic Acid; Humans; In Situ Nick-End Labeling; Microscopy, Confocal; Nanoparticles; Silicon Dioxide | 2013 |
Enhanced tumor targeting and antitumor efficacy via hydroxycamptothecin-encapsulated folate-modified N-succinyl-N'-octyl chitosan micelles.
Topics: Animals; Antineoplastic Agents, Phytogenic; Camptothecin; Cell Line, Tumor; Chitosan; Drug Carriers; Drug Delivery Systems; Folic Acid; Humans; Mice; Mice, Nude; Micelles; Neoplasms; Rats | 2013 |
Near-infrared-controlled, targeted hydrophobic drug-delivery system for synergistic cancer therapy.
Topics: Animals; Antineoplastic Agents; Camptothecin; Drug Delivery Systems; Folic Acid; Gold; HeLa Cells; Humans; Hydrophobic and Hydrophilic Interactions; Infrared Rays; Mice; Nanotubes; Polyethylene Glycols; Spectroscopy, Near-Infrared; Temperature | 2013 |
Synthesis and activity of a folate targeted monodisperse PEG camptothecin conjugate.
Topics: Antineoplastic Agents, Phytogenic; Camptothecin; Drug Delivery Systems; Folate Receptors, GPI-Anchored; Folic Acid; Humans; KB Cells; Neoplasms; Polyethylene Glycols; Prodrugs | 2013 |
[Preoperative chemotherapy in the surgical treatment of colorectal liver metastases].
Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Camptothecin; Chemotherapy, Adjuvant; Colorectal Neoplasms; Disease-Free Survival; Female; Fluorouracil; Folic Acid; Hepatectomy; Hospitals, General; Humans; Irinotecan; Kaplan-Meier Estimate; Length of Stay; Liver Neoplasms; Male; Middle Aged; Neoadjuvant Therapy; Operative Time; Organoplatinum Compounds; Oxaliplatin; Surgery Department, Hospital; Treatment Outcome | 2013 |
Rational combination therapy of vintafolide (EC145) with commonly used chemotherapeutic drugs.
Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carboplatin; Cell Line, Tumor; Cell Proliferation; Cisplatin; Docetaxel; Dose-Response Relationship, Drug; Doxorubicin; Drug Synergism; Folic Acid; HeLa Cells; Humans; Irinotecan; Mice, Inbred BALB C; Mice, Inbred DBA; Mice, Nude; Neoplasms; Neoplasms, Experimental; Paclitaxel; Taxoids; Topotecan; Treatment Outcome; Vinca Alkaloids; Xenograft Model Antitumor Assays | 2014 |
Folate-decorated and reduction-sensitive micelles assembled from amphiphilic polymer-camptothecin conjugates for intracellular drug delivery.
Topics: Antineoplastic Agents, Phytogenic; Camptothecin; Cell Survival; Dose-Response Relationship, Drug; Drug Carriers; Drug Delivery Systems; Female; Folic Acid; Humans; Hydrophobic and Hydrophilic Interactions; Lactones; Micelles; Molecular Structure; Ovarian Neoplasms; Polyethylene Glycols; Surface Properties; Tissue Distribution; Tumor Cells, Cultured | 2014 |
Targeted tumor theranostics using folate-conjugated and camptothecin-loaded acoustic nanodroplets in a mouse xenograft model.
Topics: Animals; Antineoplastic Agents, Phytogenic; Camptothecin; Cell Line, Tumor; Folic Acid; Humans; Male; Mice; Mice, Inbred NOD; Mice, SCID; Nanostructures; Neoplasms; Theranostic Nanomedicine; Xenograft Model Antitumor Assays | 2015 |
A novel micelle-forming material used for preparing a theranostic vehicle exhibiting enhanced in vivo therapeutic efficacy.
Topics: Animals; Antineoplastic Agents; Camptothecin; Carbocyanines; Cell Line, Tumor; Chitosan; Delayed-Action Preparations; Drug Carriers; Female; Ferric Compounds; Fluorescence; Fluorescent Dyes; Folic Acid; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Magnetic Fields; Magnets; Mice, Nude; Micelles; Nanoparticles; Sonication | 2015 |
A study of the synergistic effect of folate-decorated polymeric micelles incorporating Hydroxycamptothecin with radiotherapy on xenografted human cervical carcinoma.
Topics: Animals; Antineoplastic Agents, Phytogenic; Camptothecin; Cell Line, Tumor; Chemoradiotherapy; Drug Delivery Systems; Female; Fluorodeoxyglucose F18; Folic Acid; G2 Phase Cell Cycle Checkpoints; HeLa Cells; Histones; Humans; Mice, Inbred BALB C; Mice, Nude; Micelles; Microscopy, Electron, Transmission; Phosphorylation; Polyesters; Polyethylene Glycols; Polymers; Positron-Emission Tomography; Uterine Cervical Neoplasms; Xenograft Model Antitumor Assays | 2016 |
Pharmacokinetics and Tissue Distribution of Folate-Decorated Human Serum Albumin Loaded With Nano-Hydroxycamptothecin for Tumor Targeting.
Topics: Animals; Breast Neoplasms; Camptothecin; Dose-Response Relationship, Drug; Drug Carriers; Drug Delivery Systems; Female; Folic Acid; Humans; MCF-7 Cells; Mice; Mice, Inbred BALB C; Mice, Nude; Nanoparticles; Serum Albumin, Human; Tissue Distribution; Xenograft Model Antitumor Assays | 2016 |
Folate-Mediated Targeted Delivery of Combination Chemotherapeutics Loaded Reduced Graphene Oxide for Synergistic Chemo-Photothermal Therapy of Cancers.
Topics: Antineoplastic Agents; Apoptosis; Camptothecin; Cell Survival; Docetaxel; Drug Carriers; Drug Liberation; Drug Synergism; Female; Folic Acid; Graphite; Hep G2 Cells; Humans; Irinotecan; MCF-7 Cells; Nanoparticles; Particle Size; Phototherapy; Surface Properties; Taxoids | 2016 |
Preparation of Two Types of Polymeric Micelles Based on Poly(β-L-Malic Acid) for Antitumor Drug Delivery.
Topics: Antineoplastic Agents; Camptothecin; Cell Survival; Drug Compounding; Drug Delivery Systems; Drug Liberation; Folic Acid; HeLa Cells; Humans; Malates; Micelles; Microscopy, Confocal; Microscopy, Electron, Transmission; Polyethylene Glycols; Polymers | 2016 |
Synergistic antitumor efficacy of redox and pH dually responsive micelleplexes for co-delivery of camptothecin and genes.
Topics: Animals; Antineoplastic Agents; Apoptosis; Camptothecin; Cell Line, Tumor; Drug Delivery Systems; Electrophoresis, Agar Gel; Endocytosis; Female; Fluorescence; Folic Acid; Gene Transfer Techniques; Hydrogen-Ion Concentration; Mice, Inbred BALB C; Micelles; Neoplasm Metastasis; Oxidation-Reduction; Particle Size; Polyethylene Glycols; Proteins; Transfection; Tumor Burden; Tumor Necrosis Factor-alpha | 2017 |
Rapidly cell-penetrating and reductive milieu-responsive nanoaggregates assembled from an amphiphilic folate-camptothecin prodrug for enhanced drug delivery and controlled release.
Topics: A549 Cells; Antineoplastic Agents, Phytogenic; Camptothecin; Cell Line, Tumor; Delayed-Action Preparations; Drug Delivery Systems; Folic Acid; Glutathione; Humans; Neoplasms; Prodrugs | 2017 |
Folate-molecular encapsulator-tethered biocompatible polymer grafted with magnetic nanoparticles for augmented drug delivery.
Topics: beta-Cyclodextrins; Biocompatible Materials; Camptothecin; Capsules; Dextrans; Drug Carriers; Drug Liberation; Ferric Compounds; Folic Acid; HeLa Cells; Humans; Magnetite Nanoparticles; Models, Molecular; Molecular Conformation; Nickel; Zinc Compounds | 2018 |
Integration of phospholipid-hyaluronic acid-methotrexate nanocarrier assembly and amphiphilic drug-drug conjugate for synergistic targeted delivery and combinational tumor therapy.
Topics: Adenocarcinoma; Animals; Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Camptothecin; Drug Carriers; Drug Compounding; Drug Synergism; Female; Folate Receptors, GPI-Anchored; Folic Acid; Humans; Hyaluronic Acid; MCF-7 Cells; Methotrexate; Mice; Mice, Nude; Nanoparticles; Phosphatidylethanolamines; Survival Analysis; Tumor Burden; Xenograft Model Antitumor Assays | 2018 |
Methotrexate-based amphiphilic prodrug nanoaggregates for co-administration of multiple therapeutics and synergistic cancer therapy.
Topics: A549 Cells; Animals; Antineoplastic Agents; Biological Availability; Camptothecin; Disulfides; Doxorubicin; Drug Delivery Systems; Drug Evaluation, Preclinical; Drug Liberation; Drug Synergism; Female; Folic Acid; Folic Acid Transporters; HeLa Cells; Humans; Hydrazones; Lysosomes; MCF-7 Cells; Methotrexate; Mice; Mice, Inbred BALB C; Mice, Nude; Nanoparticles; Nanostructures; Neoplasm Transplantation; Neoplasms; Prodrugs | 2018 |
Folic acid-conjugated chitosan oligosaccharide-magnetic halloysite nanotubes as a delivery system for camptothecin.
Topics: Antineoplastic Agents; Camptothecin; Cell Proliferation; Cell Survival; Chitosan; Dose-Response Relationship, Drug; Drug Delivery Systems; Drug Screening Assays, Antitumor; Folic Acid; Humans; Nanotubes; Oligosaccharides; Structure-Activity Relationship; Tumor Cells, Cultured | 2018 |
Injectable Hydrogel of Vitamin B
Topics: Animals; Antineoplastic Agents; Camptothecin; CHO Cells; Cricetulus; Diffusion; Doxorubicin; Drug Carriers; Drug Liberation; Folic Acid; Gluconates; HeLa Cells; Humans; Hydrogels; Hydrogen-Ion Concentration; Hydrolysis; Hydrophobic and Hydrophilic Interactions; Lactones; Mice | 2018 |
Low-intensity focused ultrasound (LIFU)-activated nanodroplets as a theranostic agent for noninvasive cancer molecular imaging and drug delivery.
Topics: Animals; Camptothecin; Cell Line, Tumor; Cell Transformation, Neoplastic; Drug Delivery Systems; Fluorocarbons; Folic Acid; Humans; Magnetite Nanoparticles; Mice; Mice, Nude; Molecular Imaging; Nanostructures; Theranostic Nanomedicine; Tissue Distribution; Ultrasonic Waves | 2018 |
Understanding co-loading of doxorubicin and camptothecin on graphene and folic acid-conjugated graphene for targeting drug delivery: classical MD simulation and DFT calculation.
Topics: Camptothecin; Density Functional Theory; Doxorubicin; Drug Carriers; Drug Delivery Systems; Folic Acid; Graphite; Molecular Dynamics Simulation | 2020 |
β-Cyclodextrin-folate functionalized poly(lactic-co-glycolide)-superparamagnetic ytterbium ferrite hybrid nanocarrier for targeted delivery of camptothecin.
Topics: beta-Cyclodextrins; Camptothecin; Drug Carriers; Ferric Compounds; Folic Acid; Humans; Magnetic Iron Oxide Nanoparticles; Nanoparticles; Ytterbium | 2021 |
Engineering the liposomal formulations from natural peanut phospholipids for pH and temperature sensitive release of folic acid, levodopa and camptothecin.
Topics: Arachis; Camptothecin; Folic Acid; Humans; Hydrogen-Ion Concentration; Levodopa; Liposomes; Phospholipids; Temperature | 2021 |
Self-assembled Pt(II) metallacycles enable precise cancer combination chemotherapy.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Drug Liberation; Drug Synergism; Folic Acid; Humans; Mice; Nanoparticles; Neoplasms; Platinum; Polymers; Stilbenes; Tumor Microenvironment | 2022 |
Folate Decoration Supports the Targeting of Camptothecin Micelles against Activated Hepatic Stellate Cells and the Suppression of Fibrogenesis.
Topics: Animals; Camptothecin; Drug Carriers; Drug Delivery Systems; Folic Acid; Hepatic Stellate Cells; Mice; Micelles; Polyethylene Glycols | 2023 |